Concord Medical Services Holdings Limited - ADR
$3.98
$0.03
(0.76%)
As on 11-Sep-2026 15:56EDT
Market cap
$17 Mln
Revenue (TTM)
$448 Mln
P/E Ratio
--
P/B Ratio
3
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$-163 Mln
-
ROE
-0.2 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
-1
-
Debt to Equity
-1.7
-
Book Value
$--
-
EPS
$-637.4
-
Face value
--
-
Shares outstanding
2,815,458
10 Years Aggregate
CFO
CN¥-922.74 Mln
EBITDA
CN¥-1,498.04 Mln
Net Profit
CN¥-2,962.59 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Concord Medical Services Holdings Limited - ADR
| 3.1 | -8.3 | -14.0 | -29.4 | -32.3 | -33.2 | -21.0 |
|
BSE Sensex
| -11.7 | -4.8 | 1.1 | -8.2 | 3.9 | 5.1 | 10.0 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Concord Medical Services Holdings Limited - ADR
| -28.3 | -50.8 | -32.9 | -18.0 | -27.0 | 2.7 | -25.1 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Concord Medical Services Holdings Limited - ADR
|
4.0 | 17.2 | 460.5 | -92.8 | -69.6 | 4.2 | -- | 3.0 |
| 12.3 | 126.5 | 512.7 | -59.1 | -10.1 | -11.1 | -- | 1.3 |
Shareholding Pattern
View DetailsAbout Concord Medical Services Holdings Limited - ADR
Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. It operates in two segments, Network and Hospital. The company's services... include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services. Its other treatments and diagnostic services comprise positron emission tomography-computed tomography and magnetic resonance imaging scanners. In addition, the company provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, and helps to recruit and determine the compensation of doctors and other medical personnel. Further, it offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, the company operates specialty cancer hospitals, which offers radiation, imaging, test laboratory, inpatient, and nursing services. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, China. Read more
-
Chairman & CEO
Dr. Jianyu Yang
-
Chairman & CEO
Dr. Jianyu Yang
-
Headquarters
Beijing
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Concord Medical Services Holdings Limited - ADR
What is the current share price of Concord Medical Services Holdings Limited - ADR Today?
The share price of Concord Medical Services Holdings Limited - ADR is $3.98 (NYSE) as of 11-Sep-2026 15:56 EDT. Concord Medical Services Holdings Limited - ADR has given a return of -32.25% in the last 3 years.
What is the current PB & PE ratio of Concord Medical Services Holdings Limited - ADR?
Since, TTM earnings of Concord Medical Services Holdings Limited - ADR is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-0.01 |
0.00 |
2024 |
-2.27 |
-0.31 |
2023 |
0.00 |
0.00 |
2022 |
-0.44 |
-0.11 |
2021 |
-0.96 |
-0.19 |
What is the 52 Week High and Low of Concord Medical Services Holdings Limited - ADR?
The 52-week high and low of Concord Medical Services Holdings Limited - ADR are Rs 6.98 and Rs 3.18 as of 13-Sep-2026.
What is the market cap of Concord Medical Services Holdings Limited - ADR?
Concord Medical Services Holdings Limited - ADR has a market capitalisation of $ 17 Mln as on 11-Sep-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Concord Medical Services Holdings Limited - ADR?
Before investing in Concord Medical Services Holdings Limited - ADR, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.